1,2-distearoylphosphatidylethanolamine has been researched along with 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anantha, M; Bally, MB; Bregman, I; Ginj, M; Ho, EA; Osooly-Talesh, M; Ramsay, E; Sy, J; Woo, J; Yapp, DT | 1 |
1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol
| Article | Year |
|---|---|
Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties.
Topics: Animals; Antineoplastic Agents; Cations; Chemistry, Pharmaceutical; Cholesterol; Dosage Forms; Drug Delivery Systems; Female; Lipids; Liposomes; Mice; Phosphatidylethanolamines; Polyethylene Glycols; Raloxifene Hydrochloride; Tissue Distribution | 2010 |